Summary
This large-scale genetic study used multivariable Mendelian randomisation to disentangle the causal contributions of different lipoprotein lipid traits to coronary heart disease risk. Drawing on genome-wide association data from 393,193–441,016 UK Biobank participants and 60,801 CHD cases from CARDIoGRAMplusC4D, the authors identified hundreds of lipid-associated genetic variants, the majority novel, to construct causal estimates. The findings clarify which lipid biomarkers are causally implicated in CHD aetiology and their relative importance.
UK applicability
As the study was conducted using UK Biobank data, findings are directly applicable to the UK population for understanding genetic risk factors for coronary heart disease. The causal estimates may inform cardiovascular risk stratification and lipid management strategies in UK primary and secondary care.
Key measures
Odds ratios per standard-deviation-higher trait for CHD risk; genome-wide significant single nucleotide polymorphisms (SNPs) at P < 5 × 10⁻⁸; circulating concentrations of LDL cholesterol, HDL cholesterol, triglycerides, apolipoprotein B and apolipoprotein A-I
Outcomes reported
The study identified genetic variants associated with circulating lipoprotein lipid traits (LDL cholesterol, HDL cholesterol, triglycerides, apolipoprotein B and A-I) and used multivariable Mendelian randomisation to determine their causal relationships with coronary heart disease risk. The analysis quantified the independent and combined causal effects of different lipid-related entities on CHD aetiology.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.